Literature DB >> 4555825

Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers.

P C Wellings, P N Awdry, F H Bors, B R Jones, D C Brown, H E Kaufman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4555825     DOI： 10.1016/0002-9394(72)90463-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  35 in total

1.  Epidemiology and molecular analysis of herpes simplex keratitis requiring primary penetrating keratoplasty.

Authors:  B C Branco; P A Gaudio; T P Margolis
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

2.  Clinical evaluation of carbocyclic oxetanocin G eyedrops in the treatment of herpes simplex corneal ulcers.

Authors:  H Shiota; K Nitta; T Naito; Y Mimura; T Maruyama
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

Review 3.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

Review 4.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

5.  Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.

Authors:  C R Brandt; B Spencer; P Imesch; M Garneau; R Déziel
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine.

Authors:  B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

7.  Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.

Authors:  K O Smith; K S Galloway; K K Ogilvie; U O Cheriyan
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

8.  Inhibition of human cytomegalovirus by trifluorothymidine.

Authors:  S A Spector; M Tyndall; E Kelley
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Experimental herpes simplex virus type 1 encephalitis: treatment with 5-trifluoromethyl-2'-deoxyuridine.

Authors:  D W Clough; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

Review 10.  Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.